The Influence of Pharmacological Preconditioning with Sevoflurane on Incidence of Early Allograft Dysfunction in Liver Transplant Recipients

Table 5

The influence of degree of macrovesicular steatosis on IRI of grafts with and without pharmacological preconditioning.

Macrovesicular steatosis	AST		ALT
	Sevoflurane	Control	Sevoflurane	Control
None (0%)	669 (276–1327)	759 (315–1021)	421 (285–974)	413 (222–603)
Mild (1–30%)	825 (515–1654)	2571 (524–3493)	576 (363–861)	1666 (481–2642)
Moderate (31–60%)	979 (658–2267)*	4002 (2322–8601)	757 (428–1776)	1711 (940–3474)

Data are as median (interquartile range). AST: aspartate aminotransferase, ALT: alanine aminotransferase.
* 𝑃<0,05 (Mann-Whitney U-test) versus control group.